Drugs (Amendment) Rules, 2022
The Ministry of Health and Family Welfare on January 18, 2022 has issued the Drugs (Amendment) Rules, 2022 to further amend the Drugs Rules, 1945. The following amendment has been made: In rule 96, after
Drugs
-
Outpatient antibiotic prescription rate and pattern in the private sector in India: Evidence from medical audit data
<p>The key objective of this research was to generate new evidence on outpatient antibiotic prescription rate and patterns in the private sector in India. We used 12-month period (May 2013 to April 2014)
-
Addressing poverty in India’s Revised National Tuberculosis Control Programme: are we failing to harness the opportunities?
<p>The bi-directional relationship between poverty and tuberculosis (TB) is well established. Poverty aggravates material disadvantage, social exclusion, discrimination in participation across a wide range
-
Registration of healthcare facilities mandatory
These rules aim to make available a database of clinical establishments which are authorised to function and thereby improve public health quality by eliminating quacks The Union Ministry of public
-
Govt bans use of antibiotic Colistin in animal feed, poultry, aqua farms
According to the World Health Organisation (WHO), Colistin is a “reserve” antibiotic, which means it is supposed to be considered a “last-resort” option in treatment and used only in the most severe circumstances,
-
The global threat of antimicrobial resistance and the challenges and needs of Developing Countries
Antimicrobial resistance (AMR) – in which a microorganism (such as a bacterium, virus, fungus or parasite) becomes resistant to an antimicrobial drug used to treat infections caused by it – is possibly
-
Factors that get in the way of appropriate use of antimicrobial medicines in humans
In light of established principles and strategies for appropriate use of antimicrobial medicines, this paper examines studies on antimicrobial use trends across several countries in the Asia and Pacific
-
Gilead's key drug used in HIV-related infection out of reach in developing countries'
MUMBAI: Pharma major Gilead Sciences has failed to deliver on promises to make an important drug available to patients suffering from a life-threatening HIV-related infection in certain developing countries
-
Drugs of 18 pharma firms found substandard since 2018
The Bureau of Pharma PSUs of India (BPPI), which implements the Centre’s flagship affordable medicine scheme PMBJP, has found 25 batches of drugs of 18 pharmaceutical companies to be of substandard quality
-
Development of antiseptic adaptation and cross-adapatation in selected oral pathogens in vitro
<p>There is evidence that pathogenic bacteria can adapt to antiseptics upon repeated exposure. More alarming is the concomitant increase in antibiotic resistance that has been described for some pathogens.
-
Association of maternal folate intake during pregnancy with infant asthma risk
<p>Several studies assessed the association of maternal folate intake with infant asthma risk, but the fndings are controversial. We performed a meta-analysis to clarify the association between maternal